{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 65, "transaction_limit": 160, "filters": {"q": "", "ticker": "PTCT", "sector": "", "industry": "", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 65, "acquisition_count": 17, "disposal_count": 48, "acquisition_value": 4754210.95, "acquisition_value_label": "$4.8M", "disposal_value": 11322771.12, "disposal_value_label": "$11.3M", "net_value": -6568560.17, "net_value_label": "$-6.6M", "flow_tone": "negative", "largest_value_label": "$1.0M", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 65, "value": "16076982.0700", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$16.1M"}], "days": [{"transaction_date": "2026-06-22", "acquisitions": 1, "disposals": 3, "total": 4, "bar_width": 17.4}, {"transaction_date": "2026-06-24", "acquisitions": 2, "disposals": 4, "total": 6, "bar_width": 26.1}, {"transaction_date": "2026-06-25", "acquisitions": 3, "disposals": 8, "total": 11, "bar_width": 47.8}, {"transaction_date": "2026-06-26", "acquisitions": 2, "disposals": 4, "total": 6, "bar_width": 26.1}, {"transaction_date": "2026-07-06", "acquisitions": 5, "disposals": 18, "total": 23, "bar_width": 100.0}, {"transaction_date": "2026-07-07", "acquisitions": 1, "disposals": 4, "total": 5, "bar_width": 21.7}, {"transaction_date": "2026-07-09", "acquisitions": 3, "disposals": 6, "total": 9, "bar_width": 39.1}, {"transaction_date": "2026-07-14", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 4.3}], "side_mix": {"acquisitions": 17, "disposals": 48, "acquisition_share": 26.2, "disposal_share": 73.8}}, "company_flows": [{"symbol": "PTCT", "name": "PTC Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-14", "acquisitions": 17, "disposals": 48, "acquired_value": 4754210.95, "acquired_value_label": "$4.8M", "disposed_value": 11322771.12, "disposed_value_label": "$11.3M", "net_value": -6568560.17, "net_value_label": "$-6.6M", "acquisition_share": 26.2, "disposal_share": 73.8, "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}], "company_overview": [{"symbol": "PTCT", "name": "PTC Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-14", "filings": 65, "acquisitions": 17, "disposals": 48, "acquired_value": 4754210.95, "acquired_value_label": "$4.8M", "disposed_value": 11322771.12, "disposed_value_label": "$11.3M", "net_value": -6568560.17, "net_value_label": "$-6.6M", "acquisition_share": 26.2, "disposal_share": 73.8, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}], "transactions": [{"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-14", "executive": "GRAVIER, PIERRE", "executive_title": "CHIEF FINANCIAL OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3494.0, "share_price": 80.35, "transaction_value": 280742.9, "fetched_at": "2026-07-30T21:55:57.256391+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-09", "executive": "SMITH, MARY L.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10000.0, "share_price": 90.0, "transaction_value": 900000.0, "fetched_at": "2026-07-30T21:55:57.273325+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-09", "executive": "SMITH, MARY L.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 5834.0, "share_price": 90.0, "transaction_value": 525060.0, "fetched_at": "2026-07-30T21:55:57.269534+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-09", "executive": "SMITH, MARY L.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 10000.0, "share_price": 42.95, "transaction_value": 429500.0, "fetched_at": "2026-07-30T21:55:57.275344+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-09", "executive": "SMITH, MARY L.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5834.0, "share_price": 42.95, "transaction_value": 250570.3, "fetched_at": "2026-07-30T21:55:57.271717+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-09", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2464.0, "share_price": 90.25, "transaction_value": 222376.0, "fetched_at": "2026-07-30T21:55:57.277340+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-09", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2464.0, "share_price": 46.54, "transaction_value": 114674.56, "fetched_at": "2026-07-30T21:55:57.279195+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-09", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 2464.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T21:55:57.265257+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-09", "executive": "SMITH, MARY L.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 10000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T21:55:57.267603+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-09", "executive": "SMITH, MARY L.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 5834.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T21:55:57.281228+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 11369.0, "share_price": 89.03, "transaction_value": 1012182.07, "fetched_at": "2026-07-27T11:03:16.697536+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 24613.0, "share_price": 39.42, "transaction_value": 970244.46, "fetched_at": "2026-07-27T11:03:16.702278+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 9288.0, "share_price": 89.44, "transaction_value": 830718.72, "fetched_at": "2026-07-27T11:03:16.695242+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3956.0, "share_price": 87.17, "transaction_value": 344844.52, "fetched_at": "2026-07-27T11:03:16.704221+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 24613.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-27T11:03:16.699712+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10090.0, "share_price": 86.32, "transaction_value": 870968.8, "fetched_at": "2026-07-27T11:03:16.719282+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 8786.0, "share_price": 85.35, "transaction_value": 749885.1, "fetched_at": "2026-07-27T11:03:16.721228+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 18876.0, "share_price": 38.1, "transaction_value": 719175.6, "fetched_at": "2026-07-27T11:03:16.723236+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2474.0, "share_price": 87.03, "transaction_value": 215312.22, "fetched_at": "2026-07-27T11:03:16.714977+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BOULDING, MARK ELLIOTT", "executive_title": "EXEC. VP AND CLO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2813.0, "share_price": 46.54, "transaction_value": 130917.02, "fetched_at": "2026-07-27T11:03:16.740064+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2474.0, "share_price": 39.42, "transaction_value": 97525.08, "fetched_at": "2026-07-27T11:03:16.716934+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BOULDING, MARK ELLIOTT", "executive_title": "EXEC. VP AND CLO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2266.0, "share_price": 39.42, "transaction_value": 89325.72, "fetched_at": "2026-07-27T11:03:16.748898+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BOULDING, MARK ELLIOTT", "executive_title": "EXEC. VP AND CLO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1036.0, "share_price": 84.41, "transaction_value": 87448.76, "fetched_at": "2026-07-27T11:03:16.736478+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BOULDING, MARK ELLIOTT", "executive_title": "EXEC. VP AND CLO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 833.0, "share_price": 84.41, "transaction_value": 70313.53, "fetched_at": "2026-07-27T11:03:16.745338+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BOULDING, MARK ELLIOTT", "executive_title": "EXEC. VP AND CLO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 745.0, "share_price": 86.38, "transaction_value": 64353.1, "fetched_at": "2026-07-27T11:03:16.733146+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BOULDING, MARK ELLIOTT", "executive_title": "EXEC. VP AND CLO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 645.0, "share_price": 85.84, "transaction_value": 55366.8, "fetched_at": "2026-07-27T11:03:16.734853+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BOULDING, MARK ELLIOTT", "executive_title": "EXEC. VP AND CLO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 601.0, "share_price": 86.38, "transaction_value": 51914.38, "fetched_at": "2026-07-27T11:03:16.742086+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BOULDING, MARK ELLIOTT", "executive_title": "EXEC. VP AND CLO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 519.0, "share_price": 85.84, "transaction_value": 44550.96, "fetched_at": "2026-07-27T11:03:16.743619+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 426.0, "share_price": 85.28, "transaction_value": 36329.28, "fetched_at": "2026-07-27T11:03:16.727362+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 385.0, "share_price": 86.34, "transaction_value": 33240.9, "fetched_at": "2026-07-27T11:03:16.725395+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BOULDING, MARK ELLIOTT", "executive_title": "EXEC. VP AND CLO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 387.0, "share_price": 83.1, "transaction_value": 32159.7, "fetched_at": "2026-07-27T11:03:16.738278+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 811.0, "share_price": 38.1, "transaction_value": 30899.1, "fetched_at": "2026-07-27T11:03:16.729462+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BOULDING, MARK ELLIOTT", "executive_title": "EXEC. VP AND CLO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 313.0, "share_price": 83.1, "transaction_value": 26010.3, "fetched_at": "2026-07-27T11:03:16.747086+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 18876.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-27T11:03:16.710602+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 2474.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-27T11:03:16.708662+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 811.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-27T11:03:16.712988+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BOULDING, MARK ELLIOTT", "executive_title": "EXEC. VP AND CLO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 2226.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-27T11:03:16.706216+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "BOULDING, MARK ELLIOTT", "executive_title": "EXEC. VP AND CLO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 2813.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-27T11:03:16.731242+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 7718.0, "share_price": 85.26, "transaction_value": 658036.68, "fetched_at": "2026-07-16T21:47:06.621960+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 7718.0, "share_price": 38.1, "transaction_value": 294055.8, "fetched_at": "2026-07-16T21:47:06.629345+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 412.0, "share_price": 85.23, "transaction_value": 35114.76, "fetched_at": "2026-07-16T21:47:06.620339+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 412.0, "share_price": 38.1, "transaction_value": 15697.2, "fetched_at": "2026-07-16T21:47:06.627506+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 7718.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-16T21:47:06.625605+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 412.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-16T21:47:06.624007+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 11337.0, "share_price": 86.51, "transaction_value": 980763.87, "fetched_at": "2026-07-16T21:47:06.639658+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 19859.0, "share_price": 38.1, "transaction_value": 756627.9, "fetched_at": "2026-07-16T21:47:06.634041+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 8522.0, "share_price": 85.26, "transaction_value": 726585.72, "fetched_at": "2026-07-16T21:47:06.635990+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 582.0, "share_price": 85.24, "transaction_value": 49609.68, "fetched_at": "2026-07-16T21:47:06.630719+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 1001.0, "share_price": 38.1, "transaction_value": 38138.1, "fetched_at": "2026-07-16T21:47:06.646403+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 419.0, "share_price": 86.39, "transaction_value": 36197.41, "fetched_at": "2026-07-16T21:47:06.632343+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 100.0, "share_price": 87.0, "transaction_value": 8700.0, "fetched_at": "2026-07-16T21:47:06.641348+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 100.0, "share_price": 39.42, "transaction_value": 3942.0, "fetched_at": "2026-07-16T21:47:06.637999+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 1001.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-16T21:47:06.645015+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 19859.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-16T21:47:06.643295+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 100.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-16T21:47:06.648233+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 4922.0, "share_price": 85.03, "transaction_value": 418517.66, "fetched_at": "2026-07-14T22:03:14.712318+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 4922.0, "share_price": 38.1, "transaction_value": 187528.2, "fetched_at": "2026-07-14T22:03:14.719221+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 401.0, "share_price": 85.01, "transaction_value": 34089.01, "fetched_at": "2026-07-14T22:03:14.717815+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 401.0, "share_price": 38.1, "transaction_value": 15278.1, "fetched_at": "2026-07-14T22:03:14.716358+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 401.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T22:03:14.715028+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 4922.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T22:03:14.713682+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 12130.0, "share_price": 80.61, "transaction_value": 977799.3, "fetched_at": "2026-07-13T10:24:46.972889+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 11619.0, "share_price": 81.21, "transaction_value": 943578.99, "fetched_at": "2026-07-13T10:24:46.971499+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 23749.0, "share_price": 25.69, "transaction_value": 610111.81, "fetched_at": "2026-07-13T10:24:46.974287+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}, {"symbol": "PTCT", "name": "PTC Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-22", "executive": "ALMSTEAD, NEIL GREGORY", "executive_title": "CHIEF TECHNICAL OPS OFFICER", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 23749.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T10:24:46.975780+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ptct/", "research_links": {"chart": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/", "report": "/terminal/9a30a052-c427-4867-9f4c-5eaabc60614c/report/", "factor": "/factors/ticker/9a30a052-c427-4867-9f4c-5eaabc60614c/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}